Home

Pharma China Web Edition

Pharma China Archives

Online Databases

Subscription/Order/Info

Event Calendar

China Pharma Providers

About Us

	News     The Market     Industry News     Regulatory News     General Health     Legal/IPR News     Product/R&D News     API/Bulk Drug News     People in the News     Other News     Top News Worldwide Feature articles     Featured News     Editorials     Commentaries     Expert Opinions     Interviews     Case Studies     Company Profiles     Editor´s Picks General Information Full Text Title

The Market Industry News Regulatory News General Health Legal/IPR News Product/R&D News API/Bulk Drug News People in the News Other News Top News Worldwide Featured News Editorials Commentaries Expert Opinions Interviews Case Studies Company Profiles Editor´s Picks

Chinese Government Moves to Boost Healthcare As Broad Economy Weakens Further Chief Editor James Shen offers his regular monthly review of the Chinese healthcare sector with this month's emphasis on latest government actions to boost healthcare and... (4/20/2014) The Food Police: China Proposes a Plan for a Special Unit for Food and Drug Safety Violations (External) (4/21/2014) Chinese Government Moves to Boost Healthcare As Broad Economy Weakens Further (4/20/2014) China Healthcare Reform Poses Risks and Opportunities for Foreign Firms (External) (4/7/2014) Big Pharma's Rise in China Not Held Back by Scandals (4/2/2014) China and India Retains Top Positions in Healthcare M&A Space in 2013 (4/1/2014) NDRC Eyes Renewed Drug Pricing Reform Push after the "Two Sessions" (3/31/2014) RuiYi Raises US$15M to Amp Up Chinese R&D (3/28/2014) American Policy Makers Begin To Reflect on China's Pharmaceutical Sector (3/28/2014) China's Health Care Challenge (External) (3/21/2014) WHO Vaccine Preapproval Opens Door for China to Global Health Market - PATH (External) (3/19/2014) Breast Cancer Patients' Lifeline Spurs Roche China Sales: Health (External) (3/12/2014) Review of Chinese Drug Evaluation and Registration in 2013 (3/10/2014) How China's Anti-Monopoly Laws Could Impact the Pharmaceutical Sector (3/10/2014) What Money Failed To Buy: The Limits Of China's Healthcare Reform (3/5/2014) Improved Prescribing and Reimbursement Practices in Ningxia Pay-for-performance Trial (3/3/2014) Beijing Introduce Implementation Rules f...  (4/23/2014) GSK, Novartis and Eli Lilly in Three-par...  (4/23/2014) Hebei Issues 2014 Edition of Drug Reimbu...  (4/21/2014) CFDA Decentralizes Certain Approvals Rel...  (4/21/2014) Shanghai Fosun Raises Offer for Chindex ...  (4/21/2014) Pfizer Eyes AstraZeneca for US$101B Take...  (4/21/2014) Bayer China Enters Framework Agreement w...  (4/21/2014) Official Data Shows Continued Rise of Me...  (4/18/2014) Sanofi Announces Promotion Plan for Coun...  (4/18/2014) China to Push Forward Pharmaceutical Dis...  (4/18/2014) Chi-Med's JV with SinoPharm Approved and...  (4/17/2014) Chairman of China Resources Group under ...  (4/17/2014) Morgan Stanley Slashes Stake in Sihuan P...  (4/17/2014) (free) Pharma Distribution Giants Spearheads Ho...  (4/17/2014) Upcoming Event: Pharma China Annual Foru...  (4/17/2014) (free) GSK, Novartis and Eli Lilly in Three-part Mega Deals Pfizer Eyes AstraZeneca for US$101B Takeover WHO Wants HepC Drug Prices Down As It Releases First-eve... Sun Pharma Acquires Ranbaxy, Relieving Daiichi Sankyo's ... GSK to Hire In-house Doctors to Replace External Educati... Nicholas Hall Reports Continued Growth of OTC VMS Market in Chi... Chinese B2C Online Pharmacy Sales Surge 166% in 2013 Data Snapshot: 2013 CHC Prescription Drug Market in Shanghai Nicholas Hall Reports Slower Chinese OTC Drug Market Growth in ... BCG: Chinese Health and Wellness Market to Reach $70 Billion by... Shanghai Fosun Raises Offer for Chindex Acquisition by 15% Bayer China Enters Framework Agreement with China Unicom Sanofi Announces Promotion Plan for County Level Healthcare ... Chi-Med's JV with SinoPharm Approved and Operational Morgan Stanley Slashes Stake in Sihuan Pharma CFDA Decentralizes Certain Approvals Relating to Distrib... NDRC Initiates Price/Cost Survey of 60 "Randomly-selecte... CFDA Solicits Feedbacks for Draft "Provisions for Food a... France Seizes Largest Seizure of Fake Medicines in the E... NDRC to Launch New Policy Supporting Drug Innovation and... Original Pharma Sues Shandong Government over Essential Drug... SIPO Clarifies Supplemental Evidence in Pharmaceutical Paten... China Sentences Physicians and Medical Reps for Drug Sales K... Former SinoPharm VP Detained for Corruption-related Accusati... USTR Releases 2013 Report on China's WTO Compliance Highligh... DSM in Exclusive Discussions to Acquire Aland (China) USFDA to Step Up Oversight of Chinese APIs amid Fast Imp... Chongqing Porton Gets CEP for Nicotine API The Global Fund Plans Direct and Expanded Drug Procureme... EU Lifts Anti-dumpling Duties on API Dicyandiamide Recently Approved and To-Be-Approved New Drugs (Q1/2014)... Guangzhou Pharma Contracts Research Team for Class 1.1 N... SillaJen, Transgene and Lee's Pharma Confirm Clinical De... NHFPC and Army Health Department Initiate Application fo... CFDA Approves First Targeted-Drug-Delivery Stent Beijing Introduce Implementation Rules for Healthcare Co... Hebei Issues 2014 Edition of Drug Reimbursement List und... Official Data Shows Continued Rise of Medical Expenditur... China to Push Forward Pharmaceutical Distribution System... Eight Central Government Agencies Issue Policy for Suppl... Chairman of China Resources Group under Investigation for ... Recent Executive Moves CFDA Announces Senior Official Appointments and Retirement... Recent Executive Moves Recent Executive Moves Upcoming Event: Pharma China Annual Forum 2014 on April ... Upcoming Event: Pharma Business Development Course CFDA Minister Zhang Yong meets Canadian Minister of Heal... Upcoming Event: Global Mobile Health Summit Shanghai 201... Upcoming Event: Pharma China Annual Forum 2014 on April ... Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector... WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...   WiCON Officially Publishes Its...   WiCON Publishes China Pharmace...   WiCON officially publishes Chi...   Pharma China adds one more dis...   Pharma China adds another dist...

© Wicon International Group  Support by: www.heightow.com Site map | Contact Us | Links